Antigenic modulation in vitro. I. Fate of thymus-leukemia (TL) antigen-antibody complexes following modulation of TL antigenicity from the surfaces of mouse leukemia cells and thymocytes
about
Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 geneMechanisms of tumour cell escape encountered in treating lymphocytic leukaemia with anti-idiotypic antibodyAntigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia.Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody productionAugmentation of macrophage complement receptor function in vitro. I. Characterization of the cellular interactions required for the generation of a T-lymphocyte product that enhances macrophage complement receptor function.Structure of a gene encoding a murine thymus leukemia antigen, and organization of Tla genes in the BALB/c mouseInduction of resistance to antibody-mediated cytotoxicity. H-2, Ia, and Ig antigens are independent entities in the membrane of mouse lymphocytesImmunologic injury in measles virus infection. II. Suppression of immune injury through antigenic modulationAntibodies to varicella-zoster virus modulate antigen distribution but fail to induce viral persistence in vitro.Surface mapping of mouse thymocytesDevelopment of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.Prospects for the treatment of B cell tumors using idiotypic vaccination.Three major uncertainties in the antibody therapy of cancer.Do naturally occurring antibodies play a role in the progression and proliferation of tumor cells?Effect on synthetic capacity of antibodies directed against receptors of allotype-bearing rabbit cells.Inactivation or elimination of potentially trypanolytic, complement-activating immune complexes by pathogenic trypanosomes
P2860
Q28587047-AE9790DF-88A2-4275-978F-0B64A106F29CQ35991384-CEF2CC95-B2A7-4579-BA35-9857FCD2C674Q36335718-344368D2-76A9-4585-BD09-B3710F75D828Q36342627-FC8E6038-D00D-4B48-9CD9-3F7F2D38D571Q36342834-AD69489A-E080-44AE-BC25-0350C05CEED0Q36350591-A1A25155-3D35-4C1E-A869-1EB7EB627EB1Q36357974-7163621D-E470-48D0-8DC6-BFC9924DA5CCQ36358464-2E0087A7-A2C4-4E25-AD27-CC1AC9FA738AQ36687493-E54DA1FA-3BFE-45C7-AB49-A3002989CB33Q37328608-F76F94AF-465D-48EC-9EBD-73E2A48B6FBFQ37599102-A1AE0FCE-B27B-4F5A-8F7A-35CB51D2C254Q38246920-B2FB9590-0CE0-409E-9F4A-84549D257ED7Q38255786-99F021FD-3D71-4BBF-84A5-118F1DF9C34CQ39573711-3A6ECD88-8980-4E9D-AE3E-EBCD706D9ABDQ40600486-5C95ABAC-8F16-4E0B-AA1E-337EDB967E81Q40877128-358CAF2A-69A7-4858-82A5-81EC9474CDB6
P2860
Antigenic modulation in vitro. I. Fate of thymus-leukemia (TL) antigen-antibody complexes following modulation of TL antigenicity from the surfaces of mouse leukemia cells and thymocytes
description
1974 nî lūn-bûn
@nan
1974年の論文
@ja
1974年学术文章
@wuu
1974年学术文章
@zh-cn
1974年学术文章
@zh-hans
1974年学术文章
@zh-my
1974年学术文章
@zh-sg
1974年學術文章
@yue
1974年學術文章
@zh
1974年學術文章
@zh-hant
name
Antigenic modulation in vitro. ...... leukemia cells and thymocytes
@ast
Antigenic modulation in vitro. ...... leukemia cells and thymocytes
@en
type
label
Antigenic modulation in vitro. ...... leukemia cells and thymocytes
@ast
Antigenic modulation in vitro. ...... leukemia cells and thymocytes
@en
prefLabel
Antigenic modulation in vitro. ...... leukemia cells and thymocytes
@ast
Antigenic modulation in vitro. ...... leukemia cells and thymocytes
@en
P2093
P2860
P356
P1476
Antigenic modulation in vitro. ...... leukemia cells and thymocytes
@en
P2093
Jacobson JB
Stackpole CW
P2860
P304
P356
10.1084/JEM.140.4.939
P407
P577
1974-10-01T00:00:00Z